Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series: World’s leading Event Organizer
Omics International publishes 304 Open Access Articles in 13 International Journals it has 32 Upcoming Conferences and 15 Previous Conferences with 581 Conference Proceedings and 92 National symposiums so far in the field.
Anxiety is the body’s natural response to danger, an automatic alarm that goes off when you feel threatened, under pressure, or are facing a stressful situation. Anxiety is a group of related conditions rather than a single disorder; they can look very different from person to person. Despite their different forms, all anxiety disorders share one major symptom: persistent or severe fear or worry in situations where most people wouldn’t feel threatened. Medication can relieve some of the symptoms of anxiety, but it doesn’t cure the underlying problem and it’s usually not a long-term solution. Anxiety medications also come with side effects and safety concerns, such as the risk of addiction. In order to decide whether medication is right for you, it’s important to weigh the drug benefits against the drawbacks. Many different types of medications are used in the treatment of anxiety disorders, including traditional anti-anxiety drugs such as benzodiazepines, and newer options like antidepressants and beta-blockers. It’s important to be aware of the risks of anxiety medication; Anxiety medication can cause a wide range of unpleasant and sometimes dangerous side effects. Many medications for anxiety are also habit forming and physically addictive.
OMICS International through its Open access initiatives is committed to make genuine and reliable contributions to the scientific community by publishing research work and conference paper related to such disorders. It is known that OMICS Group hosts over 700 edge peer reviewed Open Access Journals which contains over 75000 eminent personalities, reputed scientists as editorial board members. Omics International organizes over more than 1000 Global Events annually with support from 1000 more scientific Societies. Its publishing group journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board that ensure a quality and quick review process checker.
Anxiety cost the U.S. more than $42 billion a year, almost one-third of the country's $148 billion total mental health bill, according to "The Economic Burden of Anxiety. More than $22.84 billion of those costs are associated with the repeated use of health care services. Clinical anxiety affected around 10 percent of people in North America, Western Europe, and Australia/New Zealand compared to about 8 percent in the Middle East and 6 percent in Asia. Both major depression and anxiety are found more commonly in women than in men. Anxiety the most common of all mental disorders currently affects about one in 13 people (7.3 percent). Approximately 12% of Canadians are affected by anxiety disorders that cause mild to severe impairment in daily living, and more than one in four Canadian workers report being highly stressed. In this session, experienced lawyers will join a mental health expert to discuss ways to monitor and reduce workplace stress and to accommodate employees living with anxiety disorders. It has been estimated that anxiety disorders affect between 5 and 7% of the general population, and that up to 29% of people will suffer from an anxiety disorder at least once during their lifetime.
List of Best International Conferences
Institutes and Associations
· The Child Mind Institute
· Anxiety Disorders Association of Victoria
· Anxiety and Depression Association of America
· Social Anxiety Association
· Canadian Mental Health Association
· Lewy Body Dementia Association
· Live strong Foundation
· Journal of Depression and Anxiety
· Journal of Psychology & Psychotherapy
· Journal of Anxiety Disorders
· Journal of Mood and Anxiety disorder
· Journal of American medical association on GAD.
· Xellia Ltd, Denmark
· Estrellas Life Sciences
· Nexus Lifecare
· Aripolis Biotech
· Abott Ltd , India
· Farma Glow, India
· Consern Pharma, India
· Neiss Labs Ltd India
· Zen lLabs, India
· Pfizer ,Multinational
· Forest Laboratories Inc , USA
· Actavis, USA
· Grapple Life Sciences
Transparency Market Research (TMR) has announced the addition report, titled “Anxiety Disorders and Depression Treatment Market 2014 - 2020”. According to this report, the global anxiety disorders and depression treatment market will demonstrate a mediocre CAGR of 1.25% during the forecast period of 2014 to 2020. In 2013, the global anxiety disorders and depression treatment market stood at US$22.5 billion in 2013 and is projected to reach US$18.2 billion by 2020.According to WHO, currently an estimated 350 million people globally are affected with depression. The primary driver of the global anxiety disorders and depression treatment market is the accelerating prevalence of depression and anxiety disorders. Prescriptions for benzodiazepines have risen 17 percent since 2006 to nearly 94 million a year; generic Xanax, called alprazolam, has increased 23 percent over the same period making it the most prescribed psycho-pharmaceutical drug, Ambien as number 2 and antidepressant Lexapro as Number 3, Valium still No. 13 among psychiatric drugs, with 14 million prescriptions. Anxiety drugs with 46 million prescriptions every year and psychiatric drugs more than 250 million times each year increasing drastically.
Sometimes being worries can be helpful when it spurs you to take action and solve a problem. On the other hand, if you’re preoccupied with “what ifs” and worst-case scenarios it becomes problematic. However unrelenting doubts and fears can be paralyzing. Unrelenting doubts also have capacity to sap your emotional energy and interfere with your daily life. It should be noted that chronic worrying is a mental habit that can be broken. However you can train your brain to stay calm and look at life from a more positive perspective.
Now a day’s different types of medications are used in the treatment of anxiety disorders which also includes traditional anti-anxiety drugs like that of benzodiazepines, antidepressants and beta-blockers. It should be noted that these medications can be very effective but they can’t cure the problem completely. However it can only can provide temporary relief instead of treating the underlying cause of the anxiety disorder. There are more chances of symptoms to return with full force if you stop taking medication. However it is very important for the patient to be aware of the risks of anxiety medication. It has been often seen that anxiety medication can cause a wide range of unpleasant and sometimes dangerous side effects.
Medication may be right for you if you have severe anxiety that’s interfering with your ability to function. It has been seen that people use anti-anxiety medication when therapy, exercise or self-help strategies would work just as well or better—minus the side effects and risks. It is obvious that therapy and self-help strategies can help you get to the bottom of your underlying issues and develop the tools to beat anxiety for good. However there are other effective treatment approaches that can be taken in addition to or instead of medications. But it is completely up to the patient to evaluate your options and decide what's best for you.
In order to explore new strategies for controlling anxiety and other related problems OMICS Group is organizing Stress Management Summit at Philadelphia during July 13-15, 2015.
OMICS Group International is an amalgamation of Open Access publications and worldwide international scientific conferences and events. In all aspects of Management, Science and Engineering and Technology, OMICS Group publishes 350 online open access scholarly journals . OMICS has 21 days rapid review process involving 30,000 editorial team members with 3.5 Million readers. OMICS ‘Open Access’ has been instrumental in taking the knowledge on science & technology to the doorsteps of ordinary men and women. Research scholars, students, libraries, educational institutions, research centres and the industries are main stakeholders that benefit greatly from this knowledge dissemination. OMICS Group also organizes 100 International conferences annually across the globe, where knowledge transfer takes place through debates, round table discussions, poster presentations, International workshops, International symposia and exhibitions.
Classes of drugs include:
Institutes and Associations
The Child Mind Institute
Anxiety Disorders Association of Victoria
Anxiety and Depression Association of America
Social Anxiety Association
Canadian Mental Health Association
Lewy Body Dementia Association
Live strong Foundation
Conferences, workshops and Symposia
ANXIETY AND DEPRESSION CONFERENCE 2015
14th International Forum on Mood and Anxiety Disorders (IFMAD 2014) Management of Mental Health Disorders
Topics in Internal Medicine and Mental Health for the Primary Care Provider 2014
27th Annual U.S. Psychiatric and Mental Health Congress 2014
World Congress of Psychiatry (WPA 2014)
Management of Mental Health Disorders: From the Nursery to the Nursing Home: Controversies in Clinical Care Co-Sponsored with School of Medicine, SUNY at Stony Brook 2014
The 16th World Congress of Psychiatry 2014
International Conference on Psychiatry and Cognitive Behavior Therapy
The International Conference on Education, Psychology and Society 2015
Annual Summit on Sleep Disorders and Medicine
This page will be updated regularly.
This page was last updated on 11th Sep, 2015
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising